Antimicrobial susceptibilities of Elizabethkingia isolate determined by MIC strips
| Antimicrobial agent . | MIC (μg/mL) . | Interpretation . |
|---|---|---|
| Ciprofloxacin | 0.25 | S |
| Amicacin | >256 | R |
| Amoxicillin | >256 | R |
| Trimethoprim-sulfamethoxazole | 0.25 | S |
| Gentamicin | >256 | R |
| Aztreonam | >64 | R |
| Ceftazidime | >256 | R |
| Tobramycin | >256 | R |
| Amoxicillin-clavulanic acid | >256 | R |
| Piperacillin-Tazobactam | 8 | S |
| Meropenem | >32 | R |
| Imipenem | >32 | R |
| Colistin | >256 | R |
| Tigercyclin | 0.25 | S |
| Vancomycin | 4 | I |
| Antimicrobial agent . | MIC (μg/mL) . | Interpretation . |
|---|---|---|
| Ciprofloxacin | 0.25 | S |
| Amicacin | >256 | R |
| Amoxicillin | >256 | R |
| Trimethoprim-sulfamethoxazole | 0.25 | S |
| Gentamicin | >256 | R |
| Aztreonam | >64 | R |
| Ceftazidime | >256 | R |
| Tobramycin | >256 | R |
| Amoxicillin-clavulanic acid | >256 | R |
| Piperacillin-Tazobactam | 8 | S |
| Meropenem | >32 | R |
| Imipenem | >32 | R |
| Colistin | >256 | R |
| Tigercyclin | 0.25 | S |
| Vancomycin | 4 | I |
Submitted isolate to Genbank (accession no. MF615392). The results were interpreted according to the recommendations of the European Committee on Antimicrobial Susceptibility Testing, version 7.1. for Staphylococcus spp. (vancomycin) and Pseudomonas aeruginosa (other antibiotics except for co-trimoxazole in which Stenotrophomonas maltophilia breakpoints were used), since there are no criteria for Elizabethkingia.